{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:15:27Z","timestamp":1790972127090,"version":"4.1.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T00:00:00Z","timestamp":1446681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0141082","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T18:42:09Z","timestamp":1446748929000},"page":"e0141082","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":64,"title":["Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT\/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1"],"prefix":"10.1371","volume":"10","author":[{"given":"Barbara","family":"Renga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Carino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Zampella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fiorucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2009.08.001","article-title":"Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders","volume":"30","author":"S Fiorucci","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/bph.12426","article-title":"GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation","volume":"17","author":"T Lieu","year":"2014","journal-title":"Br J Pharmacol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.21458","article-title":"The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells","volume":"45","author":"V Keitel","year":"2007","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0016-5085(00)70379-9","article-title":"Vasoactive agents in intrahepatic portal hypertension and fibrogenesis: implications for therapy","volume":"118","author":"DC Rockey","year":"2000","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.510280405","article-title":"Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats","volume":"28","author":"TK Gupta","year":"1998","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1172\/JCI119842","article-title":"Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in hepatic sinusoids","volume":"100","author":"V Shah","year":"1997","journal-title":"J Clin Invest"},{"key":"ref7","first-page":"G416","article-title":"Nitric oxide modulates hepatic vascular tone in normal rat liver","volume":"267","author":"MK Mittal","year":"1994","journal-title":"Am J Physiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0016-5085(99)70408-7","article-title":"Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental liver cirrhosis","volume":"117","author":"V Shah","year":"1999","journal-title":"Gastroenterology"},{"key":"ref9","first-page":"G1209","article-title":"Regulation of hepatic eNOS by caveolin and calmodulin after bile duct ligation in rats","volume":"280","author":"V Shah","year":"2001","journal-title":"Am J Physiol"},{"key":"ref10","article-title":"Cystationine \u03b3-liase, a H<sub>2<\/sub>S generating enzyme, is a GPBAR1 regulated gene and contribute to vasodilation caused by secondary bile acids","author":"B Renga","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0016-5085(81)90489-3","article-title":"Evidence for impairment of transsulfuration pathway in cirrhosis","volume":"81","author":"JH Horowitz","year":"1981","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/hep.1840080113","article-title":"S-Adenosyl-l-methionine synthase and phospholipid methyltransferase are inhibited in human cirrhosis","volume":"8","author":"A Martin-Duce","year":"1988","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev.nutr.24.012003.132418","article-title":"Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine","volume":"24","author":"MH Stipanuk","year":"2004","journal-title":"Annu Rev Nutr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1386-6346(00)00119-4","article-title":"Increased plasma homocysteine in liver cirrhosis","volume":"20","author":"A Bosy-Westphal","year":"2001","journal-title":"Hepatol Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.22037","article-title":"The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats","volume":"47","author":"E Distrutti","year":"2008","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/hep.20817","article-title":"The third gas: H<sub>2<\/sub>S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis","volume":"42","author":"S Fiorucci","year":"2005","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.gastro.2006.02.033","article-title":"The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver","volume":"131","author":"S Fiorucci","year":"2006","journal-title":"Gastroenterology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3748\/wjg.15.2097","article-title":"Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation","volume":"15","author":"B Renga","year":"2009","journal-title":"World J Gastroenterol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1096\/fj.11-195701","article-title":"Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition","volume":"26","author":"B Renga","year":"2012","journal-title":"FASEB J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/BJ20060537","article-title":"Targeted deletion of GP-BAR1 protects mice from cholesterol gallstone formation","volume":"398","author":"G Vassileva","year":"2006","journal-title":"Biochem J"},{"key":"ref21","first-page":"162","article-title":"Hemodynamic characteristics of the intrahepatic portal vascular bed over an extended flow range: a study in the isolated perfused rat liver","volume":"21","author":"HJ Grossman","year":"1995","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1021\/jm501273r","article-title":"Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands","volume":"57","author":"C Festa","year":"2014","journal-title":"J Med Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1476-5381.2011.01561.x","article-title":"Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion","volume":"165","author":"HE Parker","year":"2012","journal-title":"Br J Pharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/en.2009-0997","article-title":"Green tea polyphenol epigallocatechin gallate reduces endothelin-1 expression and secretion in vascular endothelial cells: roles for AMP-activated protein kinase, Akt, and FOXO1","volume":"151","author":"CE Reiter","year":"2010","journal-title":"Endocrinology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/jpi.12131","article-title":"Melatonin reduces endothelin-1 expression and secretion in colon cancer cells through the inactivation of FoxO-1 and NF-\u03ba\u03b2","volume":"56","author":"J Le\u00f3n","year":"2014","journal-title":"J Pineal Res"},{"key":"ref26","first-page":"925350","article-title":"FOXO transcription factors: their clinical significance and regulation","volume":"2014","author":"Y Wang","year":"2014","journal-title":"Biomed Res Int"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2174\/0929867321666131228205703","article-title":"FoxO proteins: regulation and molecular targets in liver cancer","volume":"21","author":"S Carbajo-Pescador","year":"2014","journal-title":"Curr Med Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/mol.64.4.923","article-title":"Role for nuclear factor-kappaB and signal transducer and activator of transcription 1\/interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cells","volume":"64","author":"M Woods","year":"2003","journal-title":"Mol Pharmacol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1161\/ATVBAHA.113.301565","article-title":"Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells","volume":"33","author":"T Kida","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"G652","DOI":"10.1152\/ajpgi.00143.2003","article-title":"Influence of caveolin on constitutively activated recombinant eNOS: insights into eNOS dysfunction in BDL rat liver","volume":"285","author":"H Hendrickson","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12072-015-9613-5","article-title":"New cellular and molecular targets for the treatment of portal hypertension","volume":"9","author":"J Gracia-Sancho","year":"2015","journal-title":"Hepatol Int"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3748\/wjg.v20.i10.2555","article-title":"Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis","volume":"20","author":"M Bolognesi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/jhep.2002.31432","article-title":"The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough","volume":"35","author":"R Wiest","year":"2002","journal-title":"Hepatology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1053\/j.gastro.2004.08.001","article-title":"The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis","volume":"127","author":"S Fiorucci","year":"2004","journal-title":"Gastroenterology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1124\/jpet.105.084905","article-title":"A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis","volume":"314","author":"S Fiorucci","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/jpet.105.085597","article-title":"Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis","volume":"315","author":"S Fiorucci","year":"2005","journal-title":"J Pharmacol ExpTher"},{"issue":"Suppl 1","key":"ref37","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S2210-7401(12)70015-3","article-title":"Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action","volume":"36","author":"R Poupon","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0141082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T08:47:57Z","timestamp":1567327677000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0141082"}},"subtitle":[],"editor":[{"given":"Matias A","family":"Avila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0141082","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,5]]}}}